Compounds > 18,19-dihydroetorphine
Page last updated: 2024-08-26

18,19-dihydroetorphine and Drug Withdrawal Symptoms

18,19-dihydroetorphine has been researched along with Drug Withdrawal Symptoms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's5 (71.43)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, M; Qin, BY1
Miao, H; Qin, BY1
Kaneto, H; Nakamura, F; Takahashi, M; Tokuyama, S1
Cai, ZJ; Ge, Y; Li, M; Sun, WL1
Harris, LS; Kim, SA; Martin, TJ; Smith, JE1
Bai, HQ; Li, N; Li, Y; Wu, WR; Zhang, KR; Zheng, JW1
Aceto, MD; Harris, LS; Ji, Z; Scates, SM1

Other Studies

7 other study(ies) available for 18,19-dihydroetorphine and Drug Withdrawal Symptoms

ArticleYear
[Physical dependence of dihydroetorphine in mice and monkeys (author's transl)].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1982, Volume: 3, Issue:2

    Topics: Analgesics; Animals; Etorphine; Female; Humans; Macaca mulatta; Male; Mice; Morphinans; Morphine Dependence; Opioid-Related Disorders; Substance Withdrawal Syndrome

1982
Influences of locus coeruleus lesions and reserpine treatment on opioid physical dependence in rats.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1995, Volume: 16, Issue:2

    Topics: Animals; Body Weight; Etorphine; Female; Locus Coeruleus; Male; Morphine Dependence; Neurons; Opioid-Related Disorders; Rats; Rats, Wistar; Reserpine; Substance Withdrawal Syndrome

1995
Physical dependence produced by dihydroetorphine in mice.
    Biological & pharmaceutical bulletin, 1994, Volume: 17, Issue:8

    Topics: Analgesics; Animals; Etorphine; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Morphine Dependence; Naloxone; Opioid-Related Disorders; Substance Withdrawal Syndrome

1994
[Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1994, Volume: 29, Issue:4

    Topics: Administration, Sublingual; Adolescent; Adult; Analgesics, Opioid; Etorphine; Female; Heroin; Heroin Dependence; Humans; Male; Methadone; Substance Withdrawal Syndrome; Substance-Related Disorders

1994
Potent reinforcing effects of dihydroetorphine in rats.
    European journal of pharmacology, 1997, Apr-18, Volume: 324, Issue:2-3

    Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Etorphine; Fentanyl; Heroin; Male; Morphine; Morphine Derivatives; Rats; Rats, Inbred F344; Substance Withdrawal Syndrome; Substance-Related Disorders

1997
Immunosuppressive effects of dihydroetorphine, a potent narcotic analgesic, in dihydroetorphine-dependent mice.
    European journal of pharmacology, 1999, Feb-05, Volume: 366, Issue:2-3

    Topics: Analgesics, Opioid; Animals; Antibody-Producing Cells; Body Weight; Cell Division; Dose-Response Relationship, Drug; Etorphine; Female; Hypersensitivity, Delayed; Immunosuppressive Agents; Lymphocyte Count; Lymphocyte Subsets; Lymphocytes; Lymphokines; Mice; Mice, Inbred C57BL; Naloxone; Opioid-Related Disorders; Organ Size; Spleen; Substance Withdrawal Syndrome; Thymus Gland

1999
Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.
    European journal of pharmacology, 2000, Jan-03, Volume: 387, Issue:1

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Body Weight; Dose-Response Relationship, Drug; Etorphine; Infusions, Parenteral; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors

2000